Skip to content

Zymeworks ZYME Unrealized gains (losses) on available-for-sale debt securities, tax

Unrealized gains (losses) on available-for-sale debt securities, tax at other companies

Jackson Financial logo
Jackson FinancialJXN
$2M-95.0%
Kemper logo
KemperKMPR
$8.5M+181%
BancFirst Corporation logo
BancFirst CorporationBANF
-$767K-127%
Zymeworks logo
ZymeworksZYME
$0
Equitable Holdings logo
Equitable HoldingsEQH
-$164M-195%
BankUnited logo
BankUnitedBKU
-$1.8M-110%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.79B+125%

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's unrealized gains (losses) on available-for-sale debt securities, tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's unrealized gains (losses) on available-for-sale debt securities, tax?
Zymeworks (ZYME) reported unrealized gains (losses) on available-for-sale debt securities, tax of $0 in Q1 2026.
What does unrealized gains (losses) on available-for-sale debt securities, tax mean?
The tax impact associated with unrealized gains or losses on debt securities classified as available-for-sale. This reflects the fiscal consequences of market-driven fluctuations in the value of the company's investment portfolio.